Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
H
195940
vs
K
KOSPI 200
Over the past 12 months, HK Inno.N Corp has underperformed KOSPI 200, delivering a return of -28% compared to KOSPI 200's +43% growth.
Stocks Performance
195940 vs KOSPI 200
Performance Gap
195940 vs KOSPI 200
Create a free account · No card needed
Performance By Year
195940 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
HK Inno.N Corp
Glance View
HK Inno.N Corp is a South Korean pharmaceutical company that develops, makes, and sells prescription medicines and over-the-counter health products. Its core business is branded drugs for common treatment areas such as digestive health, infections, and other medical conditions, sold through hospitals, clinics, pharmacies, and drug distributors. The company earns money mainly by selling its own medicines and health products, and in some cases by licensing drug technology or partnering with other drugmakers. It also supports its business with research and development, which helps it refresh its product line and bring new drugs to market. What sets HK Inno.N apart is that it is not just a generic drug manufacturer. It plays a more specialized role in the healthcare value chain by creating branded medicines, building clinical evidence around them, and then distributing them through the regulated medical market, where doctor and pharmacy trust matter a lot.
Create a free account · No card needed